Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC00673
   Synonyms LINC00673, HI-LNC75, HILNC75, LUCAIR1, SLNCR, SLNCR1, ERRLR01
   Region GRCh38_17:72403322-72592804    Sequence
   Ensembl NA
   RefSeq NR_036488
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods qPCR, Luciferase reporter assay, Western blot, RNAi
   Sample hepatocellular carcinoma tissues, cell lines (HCCLM3, MHCC97L,HepG2, Hep3B and Huh7,THLE-3, L-02)
   Expression Pattern up-regulated
   Function Description

LINC00673 was upregulated in HCC cancerous tissue. LINC00673 overexpression is associated with poor prognosis and low survival rate. LINC00673 silencing inhibited the proliferation,invasion and epithelial-mesenchymal transition (EMT) of HCC cells in vitro. miR-205 targeted 3'-UTR of LINC00673.miR-205 could reverse the effect of LINC00673 on HCC cells.LINC00673 silencing reduced the tumor volume and weight.

   Pubmed ID 29312806
   Year 2017
   Title Long non-coding RNA LINC00673 promotes hepatocellular carcinoma progression and metastasis through negatively regulating miR-205
   External Links
   Links for  LINC00673 GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.